Carboxymethyl Chitosan Modified Oxymatrine Liposomes for the Alleviation of Emphysema in Mice Via Pulmonary Administration

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Jun 10

PMID 35684546

Authors

Jianqing Peng

Zimin Cai

Qin Wang

Jia Zhou

Jinzhuan Xu

Di Pan

Tingting Chen

GuangQiong Zhang

Ling Tao

Yi Chen

Xiangchun Shen

Affiliations

Soon will be listed here.

Abstract

Pulmonary emphysema is a fatal lung disease caused by the progressive thinning, enlargement and destruction of alveoli that is closely related to inflammation and oxidative stress. Oxymatrine (OMT), as a bioactive constituent of traditional Chinese herbal , has great potential to alleviate pulmonary emphysema via its anti-inflammatory and antioxidative activities. Pulmonary administration is the most preferable way for the treatment of lung diseases. To improve the in vivo stability and pulmonary retention of OMT, OMT-loaded liposome with carboxymethyl chitosan (CMCS) modification was developed. The CMCS was modified on the surface of OMT liposomes via electrostatic attraction and covalent conjugation to obtain Lipo/OMT@CMCS and CMCS-Lipo/OMT, respectively. A porcine pancreatic elastase (PPE)-induced emphysema mice model was established to evaluate the alleviation effects of OMT on alveolar expansion and destruction. CMCS-modified liposomal OMT exhibited superior ameliorative effects on emphysema regardless of the preparation methods, and higher sedimentation and longer retention in the lung were observed in the CMCS-Lipo group. The mechanisms of OMT on emphysema were related to the downregulation of inflammatory cytokines and the rebalancing of antioxidant/oxidation via the Nrf2/HO-1 and NF-κB/IκB-α signaling pathways, leading to reduced cell apoptosis. Moreover, the OMT liposomal preparations further enhanced its anti-inflammatory and antioxidative effects. In conclusion, pulmonary administration of OMT is a potential strategy for the treatment of emphysema and the therapeutic effects can be further improved by CMCS-modified liposomes.

Citing Articles

Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency.

Wang Q, Bu C, Dai Q, Chen J, Zhang R, Zheng X Adv Sci (Weinh). 2024; 11(18):e2309748.

PMID: 38460157 PMC: 11095210. DOI: 10.1002/advs.202309748.

Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases.

Yong J, Shu H, Zhang X, Yang K, Luo G, Yu L Int J Nanomedicine. 2024; 19:1723-1748.

PMID: 38414528 PMC: 10898359. DOI: 10.2147/IJN.S451206.

Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy.

Harwansh R, Chauhan S, Deshmukh R, Mazumder R Curr Pharm Biotechnol. 2024; 25(14):1835-1857.

PMID: 38310453 DOI: 10.2174/0113892010282432231222060355.

PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA.

Xu Y, Zheng Y, Ding X, Wang C, Hua B, Hong S Drug Deliv. 2023; 30(1):2219870.

PMID: 37336779 PMC: 10281356. DOI: 10.1080/10717544.2023.2219870.

Development of Inhalable Chitosan-Coated Oxymatrine Liposomes to Alleviate RSV-Infected Mice.

Peng J, Wang Q, Guo M, Liu C, Chen X, Tao L Int J Mol Sci. 2022; 23(24).

PMID: 36555548 PMC: 9786244. DOI: 10.3390/ijms232415909.

References

Valenca S, Castro P, Pimenta W, Lanzetti M, Silva S, Barja-Fidalgo C . Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung. Int J Exp Pathol. 2006; 87(5):373-81. PMC: 2517381. DOI: 10.1111/j.1365-2613.2006.00492.x. View

Han W, Dong Z, Dimitropoulou C, Su Y . Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. Antioxid Redox Signal. 2011; 15(8):2121-34. PMC: 3166206. DOI: 10.1089/ars.2010.3821. View

De Leo V, Milano F, Agostiano A, Catucci L . Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles. Polymers (Basel). 2021; 13(7). PMC: 8037206. DOI: 10.3390/polym13071027. View

Xu J, Li C, Li Z, Yang C, Lei L, Ren W . Protective effects of oxymatrine against lipopolysaccharide/D‑galactosamine‑induced acute liver failure through oxidative damage, via activation of Nrf2/HO‑1 and modulation of inflammatory TLR4‑signaling pathways. Mol Med Rep. 2017; 17(1):1907-1912. DOI: 10.3892/mmr.2017.8060. View

Guo C, Zhang C, Li L, Wang Z, Xiao W, Yang Z . Hypoglycemic and hypolipidemic effects of oxymatrine in high-fat diet and streptozotocin-induced diabetic rats. Phytomedicine. 2014; 21(6):807-14. DOI: 10.1016/j.phymed.2014.02.007. View

Fischer B, Pavlisko E, Voynow J . Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011; 6:413-21. PMC: 3157944. DOI: 10.2147/COPD.S10770. View

Luo Y, Teng Z, Wang Q . Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem. 2012; 60(3):836-43. DOI: 10.1021/jf204194z. View

Vogelmeier C, Roman-Rodriguez M, Singh D, Han M, Rodriguez-Roisin R, Ferguson G . Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020; 166:105938. DOI: 10.1016/j.rmed.2020.105938. View

Antunes M, Rocco P . Elastase-induced pulmonary emphysema: insights from experimental models. An Acad Bras Cienc. 2011; 83(4):1385-96. DOI: 10.1590/s0001-37652011005000039. View

10.

Yan Y, Wu Q, Ren P, Liu Q, Zhang N, Ji Y . Zinc ions coordinated carboxymethyl chitosan-hyaluronic acid microgel for pulmonary drug delivery. Int J Biol Macromol. 2021; 193(Pt B):1043-1049. DOI: 10.1016/j.ijbiomac.2021.11.088. View

11.

Wu L, Rodriguez-Rodriguez C, Cun D, Yang M, Saatchi K, Hafeli U . Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles. Eur J Pharm Biopharm. 2020; 152:108-115. DOI: 10.1016/j.ejpb.2020.05.004. View

12.

Smola M, Vandamme T, Sokolowski A . Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomedicine. 2008; 3(1):1-19. PMC: 2526354. View

13.

Henson P, Vandivier R, Douglas I . Cell death, remodeling, and repair in chronic obstructive pulmonary disease?. Proc Am Thorac Soc. 2006; 3(8):713-7. PMC: 2647658. DOI: 10.1513/pats.200605-104SF. View

14.

Kirkham P, Rahman I . Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther. 2006; 111(2):476-94. DOI: 10.1016/j.pharmthera.2005.10.015. View

15.

Douafer H, Andrieu V, Brunel J . Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. J Control Release. 2020; 325:276-292. DOI: 10.1016/j.jconrel.2020.07.002. View

16.

Xie Y, He Q, Chen H, Lin Z, Xu Y, Yang C . Crocin ameliorates chronic obstructive pulmonary disease-induced depression via PI3K/Akt mediated suppression of inflammation. Eur J Pharmacol. 2019; 862:172640. DOI: 10.1016/j.ejphar.2019.172640. View

17.

Burns R, Anandaiah A, Rice M, Smetana G . Should You Recommend Inhaled Corticosteroids for This Patient With Chronic Obstructive Pulmonary Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2020; 172(11):735-742. DOI: 10.7326/M20-1058. View

18.

Ueno M, Maeno T, Nishimura S, Ogata F, Masubuchi H, Hara K . Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages. Nat Commun. 2015; 6:6332. DOI: 10.1038/ncomms7332. View

19.

Imai K, Mercer B, Schulman L, Sonett J, DArmiento J . Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J. 2005; 25(2):250-8. DOI: 10.1183/09031936.05.00023704. View

20.

Tang Q, Zhang W, Zhang C, Guan Y, Ding J, Yuan C . Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis. Int J Pharm. 2020; 586:119617. DOI: 10.1016/j.ijpharm.2020.119617. View